Oncolytics Biotech, Inc. (ONCY) Stock Ratings


View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:


Bullish

100% of 4 ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks
Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
siriusblack siriusblack 11/12/2014 3 months $0.84 $0.53 -37.5% -37 Active
Comments:
Netteligent Netteligent 10/16/2014 3 months $0.44 $0.53 +18.54% 18 Active
Comments:
Bee Chew Bee Chew 07/11/2014 1 Year $1.61 $0.53 -67.39% -67 Active
Comments:
ballchinnian5 ballchinnian5 04/10/2014 1 Year $1.73 $0.53 -69.65% -69 Active
Comments: Good head & neck data, massive NCI/C interest & funding
prometheusX prometheusX 04/08/2014 3 months $1.78 $1.37 -23.03% -23 Ended
Comments: After todays news a gap fill is highly possible - Reolysin could be a game changer
itssofluffyimgonnadie itssofluffyimgonnadie 01/24/2014 3 months $1.86 $1.54 -17.2% -17 Ended
Comments: This stock is undervalued
stockhawk stockhawk 11/26/2013 3 months $1.69 $1.70 +0.59% 1 Ended
Comments: This stock is undervalued
deckpal deckpal 11/23/2013 3 months $1.76 $1.66 -5.68% -5 Ended
Comments: Poised for climb
J Tyson J Tyson 11/17/2013 1 Year $2.49 $0.74 -70.28% -70 Ended
Comments: Potential for $2B/year in profits in 6 years. Risky but undervalued.
tambor tambor 04/23/2013 1 day $3.00 $2.98 -0.67% -1 Ended
Comments:
Game-On Game-On 02/24/2013 3 months $3.96 $2.62 -33.84% -33 Ended
Comments: Bullish on ONCY ... Read the full entry
mxracer617 mxracer617 01/02/2013 3 months $4.14 $4.20 +1.45% 1 Ended
Comments: new data forthcoming
JOKER66 JOKER66 12/13/2012 1 week $2.17 $3.52 +62.21% 62 Ended
Comments:
TinVestor1 TinVestor1 11/19/2012 3 months $1.99 $4.41 +121.61% 121 Ended
Comments: This stock is undervalued

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.